India likely to approve AstraZeneca vaccine by next week
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Wednesday
August 17, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WEDNESDAY, AUGUST 17, 2022
India likely to approve AstraZeneca vaccine by next week

Coronavirus chronicle

Reuters
23 December, 2020, 04:20 pm
Last modified: 23 December, 2020, 04:37 pm

Related News

  • 'They may not always appreciate it but': Jaishankar on India buying Russian oil
  • PM okays major trade deal negotiations with India
  • Eleven convicts in Gujarat gang rape, murder cases freed in India
  • Nothing personal, strictly business: Why India buys Russian oil despite Western criticism
  • 'India inflation may remain elevated despite July dip'

India likely to approve AstraZeneca vaccine by next week

Getting vaccines to the world’s second-most populous country with one of the highest infection rates will also be a big step in the battle against the pandemic

Reuters
23 December, 2020, 04:20 pm
Last modified: 23 December, 2020, 04:37 pm
India likely to approve AstraZeneca vaccine by next week

India is likely to approve Oxford/AstraZeneca's coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.

This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials.

India, the world's biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use authorisation applications for vaccines made by Pfizer Inc and local company Bharat Biotech.

Getting vaccines to the world's second-most populous country with one of the highest infection rates will also be a big step in the battle against the pandemic.

The AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates because it is cheaper, easier to transport and can be stored for long periods at normal fridge temperatures.

India's Central Drugs Standard Control Organization (CDSCO) first reviewed the three applications on Dec. 9 here and sought more information from all the companies, including from Serum Institute of India (SII), which is making the AstraZeneca shots.

SII, the world's biggest vaccine manufacturer, has now provided all the data, the two sources said. The authorities were still waiting for more details from Pfizer, a government health adviser told here a news briefing on Tuesday, while one of the sources said additional information was expected from Bharat Biotech.

Both sources said Indian health officials were in direct contact with their British counterparts over the AstraZeneca shot and that there were "strong indications" an approval would come by next week.

The expected approval comes after data from AstraZeneca's late-stage trials in the UK and Brazil released earlier this month showed the vaccine had efficacy of 62% for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose.

The Indian regulator is only considering the two full-dose regimen of the shot despite it showing a lower success rate, the sources said.

"Serum is ready," said one of the sources. "Initially, we may get around 50 million to 60 million doses."

The sources declined to be named as deliberations were ongoing and the timeline could change.

CDSCO chief V.G. Somani did not immediately respond to a request for comment. Bharat Biotech and Pfizer declined to comment, while SII did not immediately respond to an email seeking comment.

India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the AstraZeneca shot and plans to make a total of 400 million doses by July.

Top News / World+Biz

India / approve / AstraZeneca Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    People suffer as AL rally brings Dhaka to a standstill 
  • Photo: TBS
    BRT girder collapse: HC issues rule to provide Tk5cr compensation
  • A Bangladeshi family travels to a safer location as water enters new areas after the cyclone Aila hit Bangladesh in 2009. Photo: Abir Abdullah
    1cr people in Bangladesh at risk of climate change hunger in 2030

MOST VIEWED

  • People walk at a subway station, following the outbreak of the coronavirus disease (Covid-19), in Shanghai, China May 11, 2021. REUTERS/Aly Song
    Two Covid scares cause mayhem in Shanghai
  • File Photo: A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration
    Variant-adapted Covid vaccine wins first approval in Britain
  • Southern hemisphere to get first mRNA vaccine facility
    Southern hemisphere to get first mRNA vaccine facility
  • North Korea's leader Kim Jong Un greets health workers and scientists struggling with the coronavirus disease (Covid-19) pandemic during a photo session in Pyongyang, North Korea, in this undated photo released on August 10, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS
    North Korea lifts mask mandate, distancing rules after declaring Covid victory
  • A motorist passes by a mural of frontline workers against coronavirus at RK Puram in New Delhi on July 25. Delhi’s Covid-19 recoveries have outstripped new cases on almost all days this month barring a few exceptions, after ramped-up containment and testing efforts over the past month or so. (Sanchit Khanna / HT Photo)
    Delhi to enforce mask mandate again after spurt in Covid cases
  • A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell
    US CDC no longer recommends students quarantine for Covid-19 exposure

Related News

  • 'They may not always appreciate it but': Jaishankar on India buying Russian oil
  • PM okays major trade deal negotiations with India
  • Eleven convicts in Gujarat gang rape, murder cases freed in India
  • Nothing personal, strictly business: Why India buys Russian oil despite Western criticism
  • 'India inflation may remain elevated despite July dip'

Features

Photo: Collected

Which Nintendo Switch should you switch to?

1d | Brands
Photo: Collected

Welcome to the age of glass facades

1d | Habitat
Photo: Mumit M/TBS

Why artificial oyster reefs are the answer to our coastal embankments problems

1d | Panorama
Illustration: TBS

Anwar Group: From comb maker to owner of 20 companies

1d | Panorama

More Videos from TBS

Vivo to bring new phone with 'special features'

Vivo to bring new phone with 'special features'

1h | Videos
Can Bangladesh buy fuel oil from Russia?

Can Bangladesh buy fuel oil from Russia?

1h | Videos
Sony launches 'Playstation Backbone' for iPhones

Sony launches 'Playstation Backbone' for iPhones

2h | Videos
High cost of baby food a problem for people with limited income

High cost of baby food a problem for people with limited income

2h | Videos

Most Read

1
From left Afzal Karim, Murshedul Kabir and Mohammad Jahangir
Banking

Sonali, Agrani and Rupali banks get new MDs

2
Photo: TBS
Bangladesh

5 crushed to death as BRT girder falls on car in Uttara

3
Dollar price drops by Tk8 in kerb market
Economy

Dollar price drops by Tk8 in kerb market

4
Representational Image. Photo: Collected
Bangladesh

Air passengers should plan extra commute time to airport: DMP

5
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

6
Ambassador of Switzerland to Bangladesh Nathalie Chuard. Photo: Courtesy
Bangladesh

Bangladesh never asked for particular info from Swiss bank: Ambassador

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]